Single Therapeutic and Supra‐Therapeutic Doses of Ubrogepant Do Not Affect Cardiac Repolarization in Healthy Adults: Results From a Randomized Trial
Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.1696
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 14, 2019
Authors
Publisher
Wiley